Discover the detailed record of transactions filed by Gala Renee d, Director. Director active across 2 companies, notably DEXCOM INC. In total, 26 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €1.5m. Activity tracked since 3 March 2022. The latest transaction was filed on 8 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gala Renee d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
GALA RENEE D is Director at DEXCOM INC and President & CEO at Jazz Pharmaceuticals plc. She has 24 filings in total, and in the sampled recent filings, the transactions run from 2022-03-09 to 2026-06-01, with sum_buy_eur at 0 and sum_sell_eur at 1876126. The modal transaction nature is Attribution.